ZYME
Zymeworks Inc.
26.50$
-1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -258.5% | 82.4% | -375.6% | -129.9% | -36.7% | -133.8% | -12.6% | 24.8% | -113.8% | -396.9% | -1,898.6% | -696.0% | -320.7% | |
| 39.6% | 19.8% | 23.1% | 13.1% | 16.6% | 11.9% | 12.2% | 6.6% | 9.4% | 67.2% | 118.2% | 42.6% | 24.4% | |
| 12.4% | 19.9% | 35.4% | 23.7% | 29.2% | 16.2% | 23.6% | 12.0% | 25.0% | -135.6% | 288.0% | 246.9% | 58.6% | |
| 8.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -133.1% | 126.2% | -106.3% | -52.3% | 104.5% | -86.8% | 36.8% | -0.3% | -74.9% | 737.9% | -451.5% | -137.5% | -52.0% | |
| 6.9% | 10.4% | 6.5% | 5.7% | 6.3% | 1.0% | 1.2% | 1.8% | 1.5% | 22.7% | 9.0% | 4.7% | 3.8% | |
| -42.5% | -7.9% | -72.9% | -103.8% | 451.6% | -20.0% | 44.9% | 17.9% | 1.3% | 202.8% | 2,905.3% | 372.0% | 249.1% | |
| – | 4,843.2% | 3.8% | – | -128.9% | -30.4% | 0.0% | 0.0% | -58.7% | -1,006.8% | -3,162.4% | -1,131.8% | -456.9% | |
| 0.0% | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 11.5% | 299.0% | 21.2% | 5.5% | -93.7% | -27.9% | 4.9% | 2.7% | -8.9% | -746.9% | 7,424.7% | -1,089.7% | 289.6% | |
| -289.4% | 373.5% | -426.2% | -227.9% | 321.2% | -181.3% | 37.3% | 45.3% | -121.0% | -941.4% | 8,435.4% | -1,413.3% | 218.6% | |
| -265.4% | 72.1% | -382.1% | -135.6% | -42.9% | -134.8% | -13.8% | 23.0% | -115.2% | -419.6% | -1,898.6% | -696.0% | -323.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.